Brad Stanfield: Everyone Used to Take Aspirin. Then This Trial Came Out.
Peer-Reviewed Research
Key Takeaways
- Do NOT take daily aspirin for cancer prevention if you’re healthy with no history of cardiovascular events (primary prevention).
- Continue aspirin only if prescribed after a heart attack, stroke, or stent (secondary prevention) – consult your doctor before making changes.
- Be aware of increased cancer mortality risk – healthy older adults (70+) taking aspirin had 15% higher cancer death rates in the ASPREE trial.
- Understand the timeline – any negative effects disappeared when participants stopped taking aspirin.
Notable Quotes
“The data that they just published has said otherwise [to aspirin being a wonder drug]” – Suzanne G. Orchard
Bottom Line
Healthy individuals should not take daily aspirin for cancer prevention due to increased mortality risk – follow current medical guidelines which no longer recommend this practice.
Explore More
- Brad Stanfield’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network